Ischemic Stroke Clinical Trial
Official title:
A Phase II Study of Chinese Atherosclerosis Risk Evaluation: Investigation of Carotid Atherosclerotic Disease in Patients With Ischemic Cerebrovascular Events
Stroke is the first and the fourth leading cause of death in the United States and China,
respectively. Disruption of cerebrovascular vulnerable atherosclerotic plaque is the major
etiology of ischemic stroke. Therefore, early detection and treatment of vulnerable plaques
occurring at the feeding arteries to brain (cerebral arteries) will be helpful for
prevention of stroke.
Atherosclerosis is a systemic disease that usually affects multiple vascular beds. Previous
studies have shown that these high risk lesions in different segments of cerebral arteries
(intracranial and extracranial arteries) might be racially specific. It is reported that, in
stroke patients, intracranial vulnerable plaques are prevalent in Asian populations whereas
atherosclerosis more frequently involves extracranial carotid arteries in American subjects.
However, these findings are based on angiographic imaging approaches via measuring arterial
luminal stenosis. Because the atherosclerotic plaque often appears as outward expansion,
namely positive remodeling during progression, measuring luminal stenosis will underestimate
the disease severity. Hence, directly viewing the plaque in the vessel wall is strongly
suggested in order to objectively evaluate the cerebrovascular vulnerable plaque.
High resolution, black-blood magnetic resonance (MR) imaging has been widely used to
accurately characterize carotid vulnerable plaque in the last two decades. The aim of using
MR black-blood techniques is to suppress the blood signal (black) to enhance the signal
contrast between the vessel wall and blood in the arterial lumen. Excellent agreement has
been achieved between MR imaging and histology in identification of plaque components, such
as intraplaque hemorrhage and lipid core. For assessing carotid plaque, MR imaging is
superior to computed tomography and ultrasound imaging techniques due to its advantages
including noninvasive imaging, lack of ionizing radiation, excellent soft tissue resolution,
and multi-parametric image acquisition.
The Investigators hypothesize that there are specific characteristics in carotid vulnerable
plaques in Chinese patients with ischemic cerebrovascular events such as ischemic stroke and
transient ischemic attack (TIA). This study seeks to investigate the characteristics of
vulnerable plaque in carotid arteries using high resolution, black-blood MR imaging in
patients with recent TIA or ischemic stroke.
This is a cross-sectional, multicenter study. A total of 1000 patients will be recruited
from more than 10 different hospitals across China within 3 years. All patients will undergo
MR imaging for brain and carotid arteries within two weeks after symptom onset. The
prevalence of carotid vulnerable plaque and its correlations with brain ischemic lesions,
traditional risk factors, and regional distribution of China will be determined.
n/a
Observational Model: Case-Only, Time Perspective: Cross-Sectional
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Recruiting |
NCT05518305 -
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
|
||
Recruiting |
NCT06029959 -
Stroke and CPAP Outcome Study 3
|
N/A | |
Recruiting |
NCT03728738 -
Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke
|
Phase 3 | |
Terminated |
NCT03396419 -
IMPACT- 24col Collateral Blood Flow Assessment Following SPG Stimulation in Acute Ischemic Stroke (ImpACT-24B Sub-Study)
|
||
Recruiting |
NCT05065216 -
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
|
Phase 2/Phase 3 | |
Recruiting |
NCT04897334 -
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
|
N/A | |
Not yet recruiting |
NCT06462599 -
Osteopontin Gene Polymorphism in Stroke Patients in Egypt
|
||
Not yet recruiting |
NCT06026696 -
Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière
|
||
Not yet recruiting |
NCT06032819 -
Differentiating Between Brain Hemorrhage and Contrast
|
||
Recruiting |
NCT02910180 -
Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
|
||
Withdrawn |
NCT01866189 -
Identification of Hypoxic Brain Tissues by F-MISO PET in Acute Ischemic Stroke
|
N/A | |
Completed |
NCT03554642 -
Walkbot Robotic Training for Improvement in Gait
|
Phase 3 | |
Completed |
NCT02922452 -
A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT03041753 -
Reperfusion Injury After Stroke Study
|
N/A | |
Completed |
NCT02549846 -
AdminiStration of Statin On Acute Ischemic stRoke patienT Trial
|
Phase 4 | |
Completed |
NCT01678534 -
Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial
|
Phase 2 | |
Completed |
NCT02610803 -
Paroxysmal Atrial Fibrillation in Patients With Acute Ischemic Stroke
|
N/A |